- AU$135.71m
- AU$129.55m
- AU$51.13m
- 62
- 56
- 85
- 74
Annual income statement for Acusensus, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.4 | 6.75 | 28.7 | 42.6 | 51.1 |
| Cost of Revenue | |||||
| Gross Profit | 1.23 | 3.9 | 12.6 | 19 | 24.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.65 | 10.3 | 27.5 | 41.9 | 52 |
| Operating Profit | -1.26 | -3.54 | 1.21 | 0.659 | -0.913 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.26 | -3.65 | 1.16 | 0.576 | -1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.26 | -3.65 | 1.43 | 0.055 | -1.52 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.26 | -3.65 | 1.43 | 0.055 | -1.52 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.26 | -3.65 | 1.43 | 0.055 | -1.52 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.01 | -0.025 | 0.012 | 0.005 | -0.01 |
| Dividends per Share |